Sundance Strategies (SUND) 10-K 1 Jul 24 2024 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Mar. 31, 2024	Jul. 01, 2024	Sep. 30, 2023
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--03-31
Entity File Number	000-50547
Entity Registrant Name	SUNDANCE STRATEGIES, INC.
Entity Central Index Key	0001171838
Entity Tax Identification Number	88-0515333
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	4626 North 300 West
Entity Address, Address Line Two	Suite No. 365
Entity Address, City or Town	Provo
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84604
City Area Code	(801)
Local Phone Number	717-3935
Title of 12(b) Security	Common Stock, $0.001 par value
Trading Symbol	SUND
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	true
Entity Shell Company	false
Entity Public Float			$ 8,985,742
Entity Common Stock, Shares Outstanding		42,438,441
Documents Incorporated By Reference	None
ICFR Auditor Attestation Flag	false
Document Financial Statement Error Correction [Flag]	false
Auditor Firm ID	3627
Auditor Name	Sadler, Gibb & Associates, LLC
Auditor Location	Draper, UT

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Mar. 31, 2023
Current Assets
Cash and cash equivalents	$ 329,860	$ 553
Prepaid expenses and other assets	9,075	8,295
Total Current Assets	338,935	8,848
Current Liabilities
Accounts payable	447,862	753,050
Accrued expenses	433,201	574,558
Stock repurchase payable	400,000	400,000
Total Current Liabilities	1,631,063	2,903,608
Long-Term Liabilities
Accrued expenses	1,357,739	857,685
Total Long-Term Liabilities	4,647,797	3,139,148
Total Liabilities	6,278,860	6,042,756
Stockholders’ Deficit
Preferred stock, authorized 10,000,000 shares, par value $0.001; -0- shares issued and outstanding
Common stock, authorized 500,000,000 shares, par value $0.001; 42,258,441 shares issued and outstanding as of March 31, 2024; and 41,408,441 shares issued and oustanding as of March 31, 2023	42,259	41,409
Additional paid-in capital	30,914,682	28,986,558
Accumulated deficit	(36,896,866)	(35,061,875)
Total Stockholders’ Deficit	(5,939,925)	(6,033,908)
Total Liabilities and Stockholders’ Deficit	338,935	8,848
Nonrelated Party [Member]
Current Liabilities
Current portion of notes payable, related parties	300,000	300,000
Related Party [Member]
Current Liabilities
Current portion of notes payable, related parties	50,000	876,000
Long-Term Liabilities
Notes payable, related parties, net of current portion, net of debt discount	$ 3,290,058	$ 2,281,463

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2024	Mar. 31, 2023
Statement of Financial Position [Abstract]
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, shares authorized	500,000,000	500,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares issued	42,258,441	41,408,441
Common stock, shares outstanding	42,258,441	41,408,441

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Income from Investments
General and Administrative Expenses	531,406	682,283
Loss from Operations	(531,406)	(682,283)
Other Income (Expense)
Loss on extinguishment of debt	(1,047,729)	(1,745,808)
Gain on settlement of liabilities	290,000
Interest expense	(410,856)	(329,890)
Financing expense	(135,000)	(54,000)
Total Other Income (Expense)	(1,303,585)	(2,129,698)
Loss Before Income Taxes	(1,834,991)	(2,811,981)
Income Tax Provision (Benefit)
Net Loss	$ (1,834,991)	$ (2,811,981)
Loss per share - basic	$ (0.04)	$ (0.07)
Loss per share - diluted	$ (0.04)	$ (0.07)
Weighted average shares outstanding - basic	41,693,714	41,408,441
Weighted average shares outstanding - diluted	41,693,714	41,408,441

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Deficit - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Mar. 31, 2022	$ 41,409	$ 27,181,618	$ (32,249,894)	$ (5,026,867)
Balance, shares at Mar. 31, 2022	41,408,441
Warrants issued in connection with debt issuances		126,130		126,130
Warrants issued in connection to extinguishment of debt		1,678,810		1,678,810
Net loss			(2,811,981)	(2,811,981)
Balance at Mar. 31, 2023	$ 41,409	28,986,558	(35,061,875)	(6,033,908)
Balance, shares at Mar. 31, 2023	41,408,441
Warrants issued in connection with debt issuances		114,697		114,697
Warrants issued in connection to extinguishment of debt		964,277		964,277
Net loss			(1,834,991)	(1,834,991)
Common stock and warrants issued for cash	$ 850	849,150		850,000
Common stock and warrants issued for cash, shares	850,000
Balance at Mar. 31, 2024	$ 42,259	$ 30,914,682	$ (36,896,866)	$ (5,939,925)
Balance, shares at Mar. 31, 2024	42,258,441

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating Activities
Net Loss	$ (1,834,991)	$ (2,811,981)
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on extinguishment of debt	1,047,729	1,745,808
Gain on settlement of liabilities	(290,000)
Amortization of debt discount	67,890	22,487
Changes in operating assets and liabilities
Prepaid expenses and other assets	(780)	(128)
Accounts payable	(15,188)	412,023
Accrued expenses	358,697	172,078
Net Cash used in Operating Activities	(666,643)	(459,713)
Financing Activities
Proceeds from issuance of common stock and warrants – net of issuance costs	850,000
Proceeds from issuance of notes payable, related party	180,950	192,300
Repayment of notes payable, related party	(35,000)
Net Cash provided by Financing Activities	995,950	192,300
Net Change in Cash and Cash Equivalents	329,307	(267,413)
Cash and Cash Equivalents at Beginning of Period	553	267,966
Cash and Cash Equivalents at End of Period	329,860	553
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes
Non Cash Financing & Investing Activities, and Other Disclosures
Issued warrants as debt issuance costs	$ 114,697	$ 126,130

ORGANIZATION AND BASIS OF PRESE

ORGANIZATION AND BASIS OF PRESENTATION	12 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	(1) ORGANIZATION AND BASIS OF PRESENTATION Sundance Strategies, Inc. (formerly known as Java Express, Inc.) was organized under the laws of the State of Nevada on December 14, 2001, and engaged in the retail selling of beverage products to the general public until these endeavors ceased in 2006; it had no material business operations from 2006, until its acquisition of ANEW LIFE, INC. (“ANEW LIFE”), a subsidiary of Sundance Strategies, Inc. (“Sundance Strategies”, “the Company”, “we” or “our”). Our historical business model has focused on purchasing or acquiring life insurance policies and residual interests in or financial products tied to life insurance policies, including notes, drafts, acceptances, open accounts receivable and other obligations representing part or all of the sales price of insurance, life settlements and related insurance contracts being traded in the secondary marketplace, often referred to as the “life settlements market.” During the latter part of the fiscal year ended March 31, 2021, the Company began developing an additional business offering, providing professional services to specialty structured finance groups, bond issuers and life settlement aggregators. The Company has now assembled an experienced team from the life settlement marketplace, as well as from other areas such as financial services and public financial markets. As a professional services provider, the Company applies industry best practices to advise on the selection of specific portfolios of life insurance policies that are tailored to meet the needs of its clients. The Company’s clients may include bond issuers, bond investors, or other structured finance product issuers. The Company develops strategies and methodologies which include the acquisition of life insurance portfolios, then uses common structured finance techniques and proprietary analytics to structure bonds for issuances, including principal protected bonds. The Company’s goal is to deliver long-term value and profitability to shareholders by growing the Company’s professional services business and asset base, resulting in the ability to pay dividends to its shareholders. During the latter part of the year ended March 31, 2021, the Company began working closely with bond placement agents and aggregators to establish various aspects of a proprietary, investment grade bond offering. In this arrangement, the Company participates as the sole originator in the role of structuring and advising on the structure of the proprietary bond instrument. Included in the role of structuring financial assets, the Company uses proprietary analytics to establish the makeup of the rated instrument, including but not limited to, life settlement assets (life insurance policies) and managed cash, and implements a process of selective assembly of the underlying assets and cash management that will meet the policy requirements and analytics. The Company provides current and ongoing resources for all analytics, as well as advisement support for the investment and non-investment grade ratings for the managed asset pool and the managed cash accounts. In its advisory role, the Company is reimbursed for all expenses associated with the structuring and preparation of any bond offering, will receive an advisory payment upon the closing of any bond offering, and then will hold residual rights on the balance of assets once the bond is retired. On January 1, 2022, the Company entered into a marketing and consulting agreement with Tradability, LLC (“Consultant”) that requires the Company to make an initial $ 100,000 400,000 400,000 1,000,000 10,000,000 1.00 2.50 500 100 500

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	(2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Estimates Cash and Cash Equivalents Basic and Diluted Net Loss Per Common Share, 14,043,573 9,403,644 Stock-Based Compensation and Financing Cost Income Taxes The tax effects from an uncertain tax position can be recognized in the financial statements only if the position is more likely than not of being sustained if the position were to be challenged by a taxing authority. The Company has examined the tax positions taken in its tax returns and determined that there are no uncertain tax positions. As a result, the Company has recorded no uncertain tax liabilities in its balance sheet. Interest and penalties for uncertain positions, when applicable, would be recognized as a component of income tax expense. The Company files United States Federal and State income tax returns. The income tax returns of the Company are subject to examination by taxing authorities for three to five years from the date they are filed. The Company has tax returns subject to examination for 2017-2022. Principles of Consolidation Fair Value Those levels of input are summarized as follows: ● Level 1: Quoted prices in active markets for identical assets and liabilities. ● Level 2: Observable inputs other than Level 1 quoted prices, such as quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. ● Level 3: Unobservable inputs that are supported by little or no market activity. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques as well as instruments for which the determination of fair value requires significant management judgment or estimation. The level in the fair value hierarchy within which a fair value measurement in its entirety falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company did not have any transfers of assets and liabilities between Levels 1, 2 and 3 of the fair value measurement hierarchy during the years ended March 31, 2024, and 2023. The Company’s recorded values of cash and cash equivalents, accounts payable and accrued liabilities approximate their fair values based on their short-term nature. The recorded values of the Notes Payable, Related Parties and Convertible Debenture approximates the fair values as the interest rate approximates market interest rates.

NEW ACCOUNTING PRONOUNCEMENTS

NEW ACCOUNTING PRONOUNCEMENTS	12 Months Ended
	Mar. 31, 2024
Accounting Changes and Error Corrections [Abstract]
NEW ACCOUNTING PRONOUNCEMENTS	(3) NEW ACCOUNTING PRONOUNCEMENTS The Company has reviewed all other recently issued, but not yet adopted, accounting standards, in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements.

CASH AND CASH EQUIVALENTS

CASH AND CASH EQUIVALENTS	12 Months Ended
	Mar. 31, 2024
Cash and Cash Equivalents [Abstract]
CASH AND CASH EQUIVALENTS	(4) CASH AND CASH EQUIVALENTS Cash and cash equivalents consist principally of currency on hand and demand deposits at commercial banks. The Company had $ 329,860 553 250,000 79,779 0

NOTES PAYABLE

NOTES PAYABLE	12 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
NOTES PAYABLE	(5) NOTES PAYABLE On April 6, 2021, the Company borrowed $ 300,000 8 1,000,000 1.00 3 years June 9, 2023 , the unsecured promissory note with Satco International, Ltd. was amended to extend the due date from April 6, 2023 to August 31, 2024 , or at the immediate time when alternative financing or other proceeds are received. This extension has no bearing on the warrants that were issued in conjunction with the original promissory note. This note is separate from the 8 accrued interest on the note totaled $ 71,671

NOTES PAYABLE, RELATED PARTY

NOTES PAYABLE, RELATED PARTY	12 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
NOTES PAYABLE, RELATED PARTY	(6) NOTES PAYABLE, RELATED PARTY As of March 31, 2024, and 2023, the Company had borrowed $ 3,340,058 3,194,108 0 36,645 11,925 364,908 1,357,738 857,684 Related Party Promissory Notes As of both March 31, 2024, and 2023 , the Company owed $ 826,000 8 10, 2022, the notes were amended to extend the due date from October 31, 2022, or at the immediate time when alternative financing or other proceeds are received, and on June 5, 2023 and again on January 26, 2024, the notes were amended to extend the due date from July 31, 2023, to November 30, 2025, or at the immediate time when alternative financing or other proceeds are received. As per the provision outlined in Note 8, and in conjunction with the extension of the due date of the promissory notes on November 10, 2022, the Company also agreed to provide Mr. Dickman with warrants for 399,749 1,106,000 shares of common stock (see Note 8) vested immediately upon issuance, having exercise prices of $ 1.05 0.41 5 , the Company neither borrowed any additional funds under this agreement nor made any principal repayments. As of , accrued interest on the notes totaled $ 404,087 . In the event the Company completes a successful equity raise all principal and interest on the notes are due in full at that time. The total number of warrants issued to the related party lender was 3,196,332 On July 29, 2021, the Company entered into an unsecured promissory note agreement with Radiant Life, LLC. This agreement was in conjunction with the Company borrowing $ 50,000 8 July 29, 2024 . In conjunction with this specific loan event, the agreement awards Radiant Life, LLC with 50,000 1.05 , and expire in 5 , accrued interest on the note totaled $ 11,925 . Related Party Note Payable and Line of Credit Agreements As of March 31, 2024, 1,304,550 1,198,600 On February 2, 2023, and again on January 26, 2024, the related party note payable and line of credit agreement was amended to extend the due date from November 30, 2023 to November 30, 2024 and then to November 30, 2025, or at the immediate time when alternative financing or other proceeds are received March 31, 2024 4,600,000 March 31, 2023, 132,300 140,950 35,000 7.5 March 31, 2024 403,361 140,950 132,300 1,054,175 983,900 1.05 0.41 5 4,418,225 As of March 31, 2024, and 2023, the Company owed $ 1,159,508 1,119,508 2,130,000 On February 2, 2023, and again on February 1, 2024, the related party note payable and line of credit agreement was amended to extend the due date from November 30, 2023 to November 30, 2024, and later to November 30, 2025, or at the immediate time when alternative financing or other proceeds are received. 7.5 40,000 60,000 550,289 40,000 779,754 5 0.41 1.05 3,229,016

CONVERTIBLE DEBENTURE AGREEMENT

CONVERTIBLE DEBENTURE AGREEMENT	12 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
CONVERTIBLE DEBENTURE AGREEMENT	(7) CONVERTIBLE DEBENTURE AGREEMENT The Company has entered into an 8 3,000,000 Per the agreement, the number of shares issuable at conversion shall be determined by the quotient obtained by dividing the outstanding principal and accrued and unpaid interest by 90% of the 90-day average closing price of the Company’s common stock from the date the notice of conversion is received; and the price at which the Debenture may be converted will be no lower than $ 1.00 June 2, 2016 November 30, 2023 As of March 31, 2024 and March 31, 2023, the Company owed $ 0 124,225

STOCKHOLDERS_ EQUITY

STOCKHOLDERS’ EQUITY	12 Months Ended
	Mar. 31, 2024
Equity [Abstract]
STOCKHOLDERS’ EQUITY	(8) STOCKHOLDERS’ EQUITY Common Stock On August 15, 2023, the Company issued a private placement memorandum offering to raise up to $ 1,500,000 0.001 850,000 1 1,700,000 0.35 850,000 Effective December 6, 2018, three existing stockholders have contributed to the Company a portion of their common shares held at a repurchase price to the Company of $ 0.05 8,000,000 400,000 Warrants to Purchase Common Stock The following table summarizes the changes in warrants outstanding of the Company during years ended March 31, 2024, and 2023: SCHEDULE OF WARRANT OUTSTANDING Number of Warrants Weighted Average Exercise Price ($) Outstanding at March 31, 2022 9,460,611 0.54 Granted 2,153,403 1.05 Outstanding at March 31, 2023 11,614,014 0.87 Granted 4,639,929 0.51 Outstanding at March 31, 2024 14,043,573 0.75 Exercisable at March 31, 2024 16,253,943 0.75 The Company’s related party lenders consist of: the Chairman of the Board of Directors and a stockholder, Radiant Life, LLC and Mr. Dickman, a board member and stockholder. These holders of the related party unsecured promissory notes, hold agreements that provide each related party with common stock warrants upon the lender’s extension of a maturity due date or upon the loaning of additional monies. The number of warrants issued for an extension is based on the following formula: 10,000 warrants per month the due date is extended plus 1 warrant for every $2 of the principal balance outstanding (not including interest) at the time of the extension (rounded to the nearest whole warrant). 5 During the year ended March 31, 2024 the Company issued 281,900 80,000 1.05 316,756 1.049 3.36 4.29 86.52 89.11 0 During the year ended March 31, 2024, the Company issued 1,106,000 772,275 699,754 0.41 1.05 964,277 0.409 1.049 3.80 4.01 84.00 89.07 0 During the year ended March 31, 2023 the Company issued 264,600 120,000 1.05 365,502 1.049 3.62 4.31 142.23 148.56 0 The following table summarizes the warrants issued and outstanding as of March 31, 2024: SCHEDULE OF WARRANTS ISSUED AND OUTSTANDING Exercise Price ($) Warrants Outstanding Warrants Exercisable Weighted Average Remaining Contractual Life (Years) Proceeds to Company if Exercised 0.05 3,708,754 3,708,754 1.20 $ 185,439 0.35 1,700,000 1,700,000 4.50 595,000 0.41 2,035,029 2,035,029 4.83 834,362 1.00 1,000,000 1,000,000 0.02 1,000,000 1.05 5,049,790 5,049,790 3.48 5,302,280 2.00 50,000 50,000 2.34 100,000 5.00 500,000 500,000 2.82 2,500,000 14,043,573 14,043,573 $ 10,517,081 The shares of common stock issuable upon exercise of the warrants are not registered with the Securities and Exchange Commission and the holders of the warrants do not have registration rights with respect to the warrants or the underlying shares of common stock.

LIQUIDITY REQUIREMENTS AND GOIN

LIQUIDITY REQUIREMENTS AND GOING CONCERN	12 Months Ended
	Mar. 31, 2024
Liquidity Requirements And Going Concern
LIQUIDITY REQUIREMENTS AND GOING CONCERN	(9) LIQUIDITY REQUIREMENTS AND GOING CONCERN Since the Company’s inception on January 31, 2013, its operations have been primarily financed through sales of equity, debt financing from related parties and the issuance of notes payable and convertible debentures. As of March 31, 2024, the Company had $ 329,890 533 4,265,942 3,000,000 44,000 135,000 54,000 300,000 447,862 The accompanying financial statements have been prepared on a going concern basis under which the Company is expected to be able to realize its assets and satisfy its liabilities in the normal course of business.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Mar. 31, 2024
Income Tax Disclosure [Abstract]
INCOME TAXES	(10) INCOME TAXES The Company provides for income taxes under ASC 740, Income Taxes. ASC 740 requires the use of an asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. The Company recorded $ 0 The income tax provision differs from the amount of income tax determined by applying the U.S. federal tax rate of 21 SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) 2024 2023 Income tax benefit at U. S. federal statutory rates: $ (385,348 ) $ (590,516 ) State tax, net of federal benefit $ (67,408 ) (109,962 ) Permanent and other differences 258,483 463,012 Change in valuation allowance 194,273 223,229 Other 14,237 Income Tax $ - $ - The tax effects of significant items comprising the Company’s net deferred taxes as of March 31, 2024, and 2023 were as follows: SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES 2024 2023 Deferred Tax assets: Net operating loss carry forwards $ 7,620,722 $ 7,387,464 Stock and warrant compensation 479,708 479,708 Valuation allowance (8,100,430 ) (7,867,172 ) Net deferred tax asset $ - $ - The Company assesses the need for a valuation allowance against its deferred income tax assets at March 31, 2024. Factors considered in this assessment include recent and expected future earnings and the Company’s liquidity and equity positions. The Company has placed a 100 As of March 31, 2024, the Company has U.S. federal net operating loss carryforwards of $ 30,822,643 expire in 2025 Under FASB ASC 740-10-05-6, tax benefits are recognized only for the tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent The Company had no

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Mar. 31, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	(11) SUBSEQUENT EVENTS On April 19, 2024, subsequent to year end, the company paid $ 125,000 to a vendor in an effort to help secure bondin g. Between June 24, 2024, and June 25, 2024, the Company issued an additional 180,000 360,000

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Estimates	Estimates
Cash and Cash Equivalents	Cash and Cash Equivalents
Basic and Diluted Net Loss Per Common Share,	Basic and Diluted Net Loss Per Common Share, 14,043,573 9,403,644
Stock-Based Compensation and Financing Cost	Stock-Based Compensation and Financing Cost
Income Taxes	Income Taxes The tax effects from an uncertain tax position can be recognized in the financial statements only if the position is more likely than not of being sustained if the position were to be challenged by a taxing authority. The Company has examined the tax positions taken in its tax returns and determined that there are no uncertain tax positions. As a result, the Company has recorded no uncertain tax liabilities in its balance sheet. Interest and penalties for uncertain positions, when applicable, would be recognized as a component of income tax expense. The Company files United States Federal and State income tax returns. The income tax returns of the Company are subject to examination by taxing authorities for three to five years from the date they are filed. The Company has tax returns subject to examination for 2017-2022.
Principles of Consolidation	Principles of Consolidation
Fair Value	Fair Value Those levels of input are summarized as follows: ● Level 1: Quoted prices in active markets for identical assets and liabilities. ● Level 2: Observable inputs other than Level 1 quoted prices, such as quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. ● Level 3: Unobservable inputs that are supported by little or no market activity. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques as well as instruments for which the determination of fair value requires significant management judgment or estimation. The level in the fair value hierarchy within which a fair value measurement in its entirety falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company did not have any transfers of assets and liabilities between Levels 1, 2 and 3 of the fair value measurement hierarchy during the years ended March 31, 2024, and 2023. The Company’s recorded values of cash and cash equivalents, accounts payable and accrued liabilities approximate their fair values based on their short-term nature. The recorded values of the Notes Payable, Related Parties and Convertible Debenture approximates the fair values as the interest rate approximates market interest rates.

STOCKHOLDERS_ EQUITY (Tables)

STOCKHOLDERS’ EQUITY (Tables)	12 Months Ended
	Mar. 31, 2024
Equity [Abstract]
SCHEDULE OF WARRANT OUTSTANDING	The following table summarizes the changes in warrants outstanding of the Company during years ended March 31, 2024, and 2023: SCHEDULE OF WARRANT OUTSTANDING Number of Warrants Weighted Average Exercise Price ($) Outstanding at March 31, 2022 9,460,611 0.54 Granted 2,153,403 1.05 Outstanding at March 31, 2023 11,614,014 0.87 Granted 4,639,929 0.51 Outstanding at March 31, 2024 14,043,573 0.75 Exercisable at March 31, 2024 16,253,943 0.75
SCHEDULE OF WARRANTS ISSUED AND OUTSTANDING	The following table summarizes the warrants issued and outstanding as of March 31, 2024: SCHEDULE OF WARRANTS ISSUED AND OUTSTANDING Exercise Price ($) Warrants Outstanding Warrants Exercisable Weighted Average Remaining Contractual Life (Years) Proceeds to Company if Exercised 0.05 3,708,754 3,708,754 1.20 $ 185,439 0.35 1,700,000 1,700,000 4.50 595,000 0.41 2,035,029 2,035,029 4.83 834,362 1.00 1,000,000 1,000,000 0.02 1,000,000 1.05 5,049,790 5,049,790 3.48 5,302,280 2.00 50,000 50,000 2.34 100,000 5.00 500,000 500,000 2.82 2,500,000 14,043,573 14,043,573 $ 10,517,081

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Mar. 31, 2024
Income Tax Disclosure [Abstract]
SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT)	SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) 2024 2023 Income tax benefit at U. S. federal statutory rates: $ (385,348 ) $ (590,516 ) State tax, net of federal benefit $ (67,408 ) (109,962 ) Permanent and other differences 258,483 463,012 Change in valuation allowance 194,273 223,229 Other 14,237 Income Tax $ - $ -
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES	The tax effects of significant items comprising the Company’s net deferred taxes as of March 31, 2024, and 2023 were as follows: SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES 2024 2023 Deferred Tax assets: Net operating loss carry forwards $ 7,620,722 $ 7,387,464 Stock and warrant compensation 479,708 479,708 Valuation allowance (8,100,430 ) (7,867,172 ) Net deferred tax asset $ - $ -

ORGANIZATION AND BASIS OF PRE_2

ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) $ / shares in Units, Integer in Millions		12 Months Ended
	Jan. 02, 2022 USD ($) Integer $ / shares shares	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)
Property, Plant and Equipment [Line Items]
Repayment of related party debt		$ 35,000
Proceeds from issuance of upon contingent milestones	$ 400,000
Consulting Agreement [Member]
Property, Plant and Equipment [Line Items]
Payments to acquire loans held-for-investment	100,000
Consulting Agreement [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Repayment of related party debt	$ 400,000
Stock option granted | shares	10,000,000
Share based compensation exercise price per share | $ / shares	$ 2.50
Proceeds from non fungible token	$ 500,000,000
Consulting Agreement [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Stock option granted | shares	1,000,000
Share based compensation exercise price per share | $ / shares	$ 1
Number of milestone non fungible | Integer	500
Proceeds from non fungible token	$ 100,000,000

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - shares	12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Accounting Policies [Abstract]
Potentially dilutive securities outstanding	14,043,573	9,403,644

CASH AND CASH EQUIVALENTS (Deta

CASH AND CASH EQUIVALENTS (Details Narrative) - USD ($)	Mar. 31, 2024	Mar. 31, 2023
Cash and Cash Equivalents [Abstract]
Cash and cash equivalents	$ 329,860	$ 553
FDIC insured amount	250,000
FDIC insured amounts	$ 79,779	$ 0

NOTES PAYABLE (Details Narrativ

NOTES PAYABLE (Details Narrative) - USD ($)	Jun. 09, 2023	Jan. 06, 2022	Mar. 31, 2024	Apr. 06, 2021
Short-Term Debt [Line Items]
Debt instrument, interest rate, stated percentage				8%
Issuance of warrants			1,106,000
Interest payable			$ 404,087
8% Convertible Debenture Agreement [Member] | Satco International Ltd [Member]
Short-Term Debt [Line Items]
Debt instrument, interest rate, stated percentage			8%
Debt instrument, maturity date, description	April 6, 2023 to August 31, 2024
Unsecured Promissory Note [Member]
Short-Term Debt [Line Items]
Notes payable				$ 300,000
Debt instrument, interest rate, stated percentage				8%
Issuance of warrants				1,000,000
Warrant exercisable price per share				$ 1
Promissory note expiring		3 years
Interest payable			$ 71,671

NOTES PAYABLE, RELATED PARTY (D

NOTES PAYABLE, RELATED PARTY (Details Narrative) - USD ($)		12 Months Ended
	Jul. 29, 2021	Mar. 31, 2024	Mar. 31, 2023	Nov. 10, 2022	Apr. 06, 2021
Short-Term Debt [Line Items]
Accrued interest current		$ 124,225	$ 124,225
Accrued interest		$ 404,087
Debt instrument interest rate					8%
Issuance of warrants		1,106,000
Repayments of related party debt		$ 35,000
Notes Payable and Lines of Credit Agreement [Member] | Maximum [Member]
Short-Term Debt [Line Items]
Note payable		$ 4,600,000
Line of Credit Agreement [Member]
Short-Term Debt [Line Items]
Repayments of related party debt			132,300
Radiant Life LLC [Member]
Short-Term Debt [Line Items]
Warrant exercise price per share	$ 1.05
Warrant term	5 years	5 years
Issuance of warrants	50,000
Mr. Dickman [Member] | Maximum [Member]
Short-Term Debt [Line Items]
Warrant exercise price per share		$ 1.05
Mr. Dickman [Member] | Minimum [Member]
Short-Term Debt [Line Items]
Warrant exercise price per share		$ 0.41
Common Stock [Member] | Mr. Dickman [Member]
Short-Term Debt [Line Items]
Number of warrants				399,749
Unsecured Promissory Note [Member]
Short-Term Debt [Line Items]
Note payable					$ 300,000
Accrued interest		$ 71,671
Debt instrument interest rate					8%
Warrant exercise price per share					$ 1
Issuance of warrants					1,000,000
Related Party [Member]
Short-Term Debt [Line Items]
Note payable		3,340,058	3,194,108
Unamortized debt discount		0	36,645
Accrued interest current		11,925	364,908
Accrued interest		1,357,738	857,684
Related Party [Member] | Unsecured Promissory Note [Member] | Mr Glenn S Dickman [Member]
Short-Term Debt [Line Items]
Note payable		$ 826,000	$ 826,000
Mr Glenn S Dickman [Member] | Unsecured Promissory Note [Member]
Short-Term Debt [Line Items]
Debt instrument interest rate		8%	8%
Common stock warrant		1,106,000
Kraig T. Higginson [Member]
Short-Term Debt [Line Items]
Note payable		$ 1,304,550	$ 1,198,600
Accrued interest		$ 403,361
Debt instrument interest rate		7.50%
Warrant exercise price per share		$ 1.05	$ 0.41
Warrant term		5 years	5 years
Issuance of warrants		1,054,175	983,900
Repayments of related party debt		$ 140,950	$ 132,300
Kraig T. Higginson [Member] | Notes Payable and Lines of Credit Agreement [Member]
Short-Term Debt [Line Items]
Description of maturity date		On February 2, 2023, and again on January 26, 2024, the related party note payable and line of credit agreement was amended to extend the due date from November 30, 2023 to November 30, 2024 and then to November 30, 2025, or at the immediate time when alternative financing or other proceeds are received
Kraig T. Higginson [Member] | Lines of Credit Agreement [Member]
Short-Term Debt [Line Items]
Repayments of related party debt		$ 35,000
Related Party Lender [Member]
Short-Term Debt [Line Items]
Issuance of warrants		3,196,332
Radiant Life LLC [Member]
Short-Term Debt [Line Items]
Note payable		$ 1,159,508	1,119,508
Accrued interest		$ 550,289
Debt instrument interest rate		7.50%
Warrant term		5 years
Issuance of warrants		779,754
Repayments of related party debt		$ 40,000	$ 60,000
Radiant Life LLC [Member] | Maximum [Member]
Short-Term Debt [Line Items]
Warrant exercise price per share		$ 1.05
Line of credit		$ 2,130,000
Radiant Life LLC [Member] | Minimum [Member]
Short-Term Debt [Line Items]
Warrant exercise price per share		$ 0.41
Radiant Life LLC [Member] | Notes Payable and Lines of Credit Agreement [Member]
Short-Term Debt [Line Items]
Description of maturity date		On February 2, 2023, and again on February 1, 2024, the related party note payable and line of credit agreement was amended to extend the due date from November 30, 2023 to November 30, 2024, and later to November 30, 2025, or at the immediate time when alternative financing or other proceeds are received.
Radiant Life LLC [Member] | Unsecured Promissory Note [Member]
Short-Term Debt [Line Items]
Note payable	$ 50,000
Accrued interest		$ 11,925
Debt instrument interest rate	8%
Debt maturity date	Jul. 29, 2024
Related Party Lender One [Member]
Short-Term Debt [Line Items]
Issuance of warrants		4,418,225
Related Party Lender Two [Member]
Short-Term Debt [Line Items]
Issuance of warrants		3,229,016

CONVERTIBLE DEBENTURE AGREEME_2

CONVERTIBLE DEBENTURE AGREEMENT (Details Narrative) - USD ($)	12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Apr. 06, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Interest rate			8%
Accrued interest	$ 124,225	$ 124,225
Related Party [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Amount payable	0	0
Accrued interest	$ 11,925	$ 364,908
8% Convertible Debenture Agreement [Member] | Satco International Ltd [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Interest rate	8%
Debt borrowing amount	$ 3,000,000
Description of convertible terms of conversion	Per the agreement, the number of shares issuable at conversion shall be determined by the quotient obtained by dividing the outstanding principal and accrued and unpaid interest by 90% of the 90-day average closing price of the Company’s common stock from the date the notice of conversion is received; and the price at which the Debenture may be converted will be no lower than $1.00 per share.
Debt convertible conversion price per share	$ 1
Debt maturity date	Jun. 02, 2016
8% Convertible Debenture Agreement [Member] | Satco International Ltd [Member] | Extended Maturity [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Debt maturity date	Nov. 30, 2023

SCHEDULE OF WARRANT OUTSTANDING

SCHEDULE OF WARRANT OUTSTANDING (Details) - $ / shares	12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Equity [Abstract]
Number of Warrants Outstanding, Beginning Balance	11,614,014	9,460,611
Weighted Average Exercise Price, Beginning Balance	$ 0.87	$ 0.54
Number of Warrants, Granted	4,639,929	2,153,403
Weighted Average Exercise Price, Granted	$ 0.51	$ 1.05
Number of Warrants Outstanding, Ending Balance	14,043,573	11,614,014
Weighted Average Exercise Price, Ending Balance	$ 0.75	$ 0.87
Number of Warrants Exercisable	16,253,943
Weighted Average Exercise Price,Exercisable	$ 0.75

SCHEDULE OF WARRANTS ISSUED AND

SCHEDULE OF WARRANTS ISSUED AND OUTSTANDING (Details) - USD ($)	12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2022
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Warrant Outstanding	14,043,573	11,614,014	9,460,611
Warrants Exercisable	14,043,573
Proceeds from Warrant Exercised	$ 10,517,081
Exercise Price One [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Warrant Exercise Price	$ 0.05
Warrant Outstanding	3,708,754
Warrants Exercisable	3,708,754
Weighted Average Remaining Contractual Life (Years)	1 year 2 months 12 days
Proceeds from Warrant Exercised	$ 185,439
Exercise Price Two [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Warrant Exercise Price	$ 0.35
Warrant Outstanding	1,700,000
Warrants Exercisable	1,700,000
Weighted Average Remaining Contractual Life (Years)	4 years 6 months
Proceeds from Warrant Exercised	$ 595,000
Exercise Price Three [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Warrant Exercise Price	$ 0.41
Warrant Outstanding	2,035,029
Warrants Exercisable	2,035,029
Weighted Average Remaining Contractual Life (Years)	4 years 9 months 29 days
Proceeds from Warrant Exercised	$ 834,362
Exercise Price Four [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Warrant Exercise Price	$ 1
Warrant Outstanding	1,000,000
Warrants Exercisable	1,000,000
Weighted Average Remaining Contractual Life (Years)	7 days
Proceeds from Warrant Exercised	$ 1,000,000
Exercise Price Five [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Warrant Exercise Price	$ 1.05
Warrant Outstanding	5,049,790
Warrants Exercisable	5,049,790
Weighted Average Remaining Contractual Life (Years)	3 years 5 months 23 days
Proceeds from Warrant Exercised	$ 5,302,280
Exercise Price Six [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Warrant Exercise Price	$ 2
Warrant Outstanding	50,000
Warrants Exercisable	50,000
Weighted Average Remaining Contractual Life (Years)	2 years 4 months 2 days
Proceeds from Warrant Exercised	$ 100,000
Exercise Price Seven [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Warrant Exercise Price	$ 5
Warrant Outstanding	500,000
Warrants Exercisable	500,000
Weighted Average Remaining Contractual Life (Years)	2 years 9 months 25 days
Proceeds from Warrant Exercised	$ 2,500,000

STOCKHOLDERS_ EQUITY (Details N

STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)				12 Months Ended
	Oct. 04, 2023	Aug. 15, 2023	Dec. 06, 2018	Mar. 31, 2024	Mar. 31, 2023	Jul. 29, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Proceeds from issuance of private placement		$ 1,500,000
Preferred stock, par value		$ 0.001		$ 0.001	$ 0.001
Number of warrants				1,106,000
Radiant Life LLC [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of warrants						50,000
Warrant exercisable price per share						$ 1.05
Warrant or right, reason for issuance, description				The number of warrants issued for an extension is based on the following formula: 10,000 warrants per month the due date is extended plus 1 warrant for every $2 of the principal balance outstanding (not including interest) at the time of the extension (rounded to the nearest whole warrant).
Warrant term				5 years		5 years
Three Existing Shareholders [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock repurchase, price per share			$ 0.05
Number of shares cancelled/retired			8,000,000
Number of stock value repurchased			$ 400,000
Chairman Of The Board Directors [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of warrants				281,900	264,600
Warrant exercisable price per share				$ 1.05	$ 1.05
Fair value of common stock				$ 1.049	$ 1.049
Dividend rate				0%	0%
Chairman Of The Board Directors [Member] | Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free rate				3.36%	3.62%
Volatility rate				86.52%	142.23%
Chairman Of The Board Directors [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free rate				4.29%	4.31%
Volatility rate				89.11%	148.56%
Chairman Of The Board Directors [Member] | Valuation Technique, Option Pricing Model [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Value of the warrants				$ 316,756	$ 365,502
Mr. Dickman [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Dividend rate				0%
Mr. Dickman [Member] | Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant exercisable price per share				$ 0.41
Fair value of common stock				$ 0.409
Risk-free rate				3.80%
Volatility rate				84%
Mr. Dickman [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant exercisable price per share				$ 1.05
Fair value of common stock				$ 1.049
Risk-free rate				4.01%
Volatility rate				89.07%
Mr. Dickman [Member] | Valuation Technique, Option Pricing Model [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Value of the warrants				$ 964,277
Subscription Agreements [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Subscription receivable	$ 850,000
Purchase price per shares	$ 1
Number of warrants	1,700,000
Warrant exercisable price per share	$ 0.35
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Subscription receivable	$ 850,000
Warrant [Member] | Chairman Of The Board Directors [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of warrants				80,000	120,000
Warrant [Member] | Board of Directors [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of warrants				772,275
Warrant [Member] | Mr. Dickman [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of warrants				699,754

LIQUIDITY REQUIREMENTS AND GO_2

LIQUIDITY REQUIREMENTS AND GOING CONCERN (Details Narrative) - USD ($)	12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Liquidity Requirements And Going Concern
Cash	$ 329,890	$ 533
Additional borrowing capacity from related party notes payable	4,265,942
Additional borrowing capacity from convertible debenture	3,000,000
Operating expenses	44,000
Financing interest expense	135,000	$ 54,000
Additional financing alternatives	300,000
Accounts payable	$ 447,862

SCHEDULE OF COMPONENTS OF INCOM

SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) (Details) - USD ($)	12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Income tax benefit at U. S. federal statutory rates:	$ (385,348)	$ (590,516)
State tax, net of federal benefit	(67,408)	(109,962)
Permanent and other differences	258,483	463,012
Change in valuation allowance	194,273	223,229
Other		14,237
Income Tax

SCHEDULE OF DEFERRED TAX ASSETS

SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)	Mar. 31, 2024	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Net operating loss carry forwards	$ 7,620,722	$ 7,387,464
Stock and warrant compensation	479,708	479,708
Valuation allowance	(8,100,430)	(7,867,172)
Net deferred tax asset

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative) - USD ($)	12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Provision for income taxes
Federal statutory income tax rate, percent	21%	21%
Valuation allowance on eferred tax assets, percentage	100%
Operating loss carryforwards	$ 30,822,643
Operating loss carryforwards expiration date, description	expire in 2025
Income tax examination, likelihood of unfavorable settlement	greater than 50 percent
Unrecognized tax benefits	$ 0	$ 0

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)			12 Months Ended
	Jun. 25, 2024	Apr. 19, 2024	Mar. 31, 2024	Mar. 31, 2023
Subsequent Event [Line Items]
Repayments of Related Party Debt			$ 35,000
Number of warrants issued			1,106,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Repayments of Related Party Debt		$ 125,000
Subsequent Event [Member] | Investor [Member]
Subsequent Event [Line Items]
Number of shares	180,000
Number of warrants issued	360,000